- Scarlet acid
-
-
2025-06-27
- CAS:134-47-4
- Min. Order: 1KG
- Purity: 99%
- Supply Ability: 500000kg
- Scarlet acid
-
- $60.00
-
2025-06-20
- CAS:134-47-4
- Min. Order: 1kg
- Purity: 0.99
- Supply Ability: 25 tons
|
| | 6,6'-Ureylene-bis(1-naphthol-3-sulfonic acid) Basic information |
| Product Name: | 6,6'-Ureylene-bis(1-naphthol-3-sulfonic acid) | | Synonyms: | 4,4'-dihydroxy-7,7'-ureylenedi(naphthalene-2-sulphonic acid);7,7'-(Carbonyldiimino)bis[4-hydroxy-2-naphthalenesulfonic acid];6,6'-ureylene-bis(1-naphthol-3-sulfonic acid);phosgenated;N,N'-bis(4-hydroxy-2-sulfonaphthalene-7-yl)urea;7,7'-Ureylenebis(4-hydroxy-2-naphthalenesulfonic acid);N,N'-Bis[6-(1-naphthol-3-sulfonic acid)]urea;6,6'-ureylenbis-1-naphthol-3-sulfonic acid | | CAS: | 134-47-4 | | MF: | C21H16N2O9S2 | | MW: | 504.49 | | EINECS: | 205-142-9 | | Product Categories: | Intermediates of Dyes and Pigments | | Mol File: | 134-47-4.mol |  |
| | 6,6'-Ureylene-bis(1-naphthol-3-sulfonic acid) Chemical Properties |
| | 6,6'-Ureylene-bis(1-naphthol-3-sulfonic acid) Usage And Synthesis |
| Uses | 7,7''-(Carbonylbis(azanediyl))bis(4-hydroxynaphthalene-2-sulfonic acid) (cas# 134-47-4) is a pharmacologically active compound capable of selective nonbisphosphonate inhibition of human geranylgeranyl diphosphate synthase, and inhibition of shikimate dehydrogenase and shikimate kinase in shikimate pathway of Helicobacter pylori. | | Preparation | 7,7' -Urylenebis(4-hydroxynaphthalene-2- sulfonic acid) [134-47-4] , J acid urea, carbonyl J acid, is produced by reacting the sodium salt of J acid with phosgene in aqueous solution at 30℃ and maintaining alkalinity with sodium carbonate. After being heated to 80℃, the product is salted out with sodium chloride (yield ca. 100 %). It is used to produce C.I. Direct Orange 26; C.I. Direct Reds 4, 14, 23, and 80; and C.I. Direct Brown 112. | | in vivo | AMI-1 free acid (0.5 mg; intratumorally; daily; for 7 days) inhibits S180 viability in vivo[4].
AMI-1 free acid (0.5 mg; intratumorally; daily; for 7 days) downregulates PRMT5 but does not regulate the expression of PRMT7 in a tumor xenograft model[4].
AMI-1 free acid (0.5 mg; intratumorally; daily; for 7 days) decreases the levels of H4R3me2s and H3R8me2s in a tumor xenograft model[4].
| Animal Model: | 6-7 weeks old male Kunming mice (18-22 g), with S180 cells xenograft[4] | | Dosage: | 0.5 mg | | Administration: | Intratumorally, daily, for 7 days | | Result: | Decreased tumor weight. |
|
| | 6,6'-Ureylene-bis(1-naphthol-3-sulfonic acid) Preparation Products And Raw materials |
| Raw materials | Sodium bisulfite-->Sodium metabisulfite | | Preparation Products | Direct Red 23-->Direct Orange S-->Copper, 2,2'-[carbonylbis[imino(1-hydroxy-3-sulfo-6,2-naphthalenediyl)azo]]bis[benzoic acid] complex-->trisodium [mu-[2-[[1-hydroxy-6-[[[[5-hydroxy-6-[(2-hydroxy-5-sulphophenyl)azo]-7-sulpho-2-naphthyl]amino]carbonyl]amino]-3-sulpho-2-naphthyl]azo]benzoato(7-)]]dicuprate(3-)-->tetrasodium [mu-[[7,7'-(carbonyldiimino)bis[4-hydroxy-3-[(2-hydroxy-5-sulphophenyl)azo]naphthalene-2-sulphonato]](8-)]]dicuprate(4-)-->Leather Black-->DIRECT ORANGE 118-->DIRECT RED 26-->7,7'-(Carbonyldiimino)bis[4-hydroxy-3-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenesulfonic acid]disodium salt-->DIRECT ORANGE 26-->DIRECT RED 4-->trisodium [mu-[2-[[1-hydroxy-6-[[[[5-hydroxy-6-[(2-hydroxy-5-sulphophenyl)azo]-7-sulpho-2-naphthyl]amino]carbonyl]amino]-3-sulpho-2-naphthyl]azo]benzoato(7-)]]dicuprate(3-)-->Direct Violet 89-->Direct red 72-->C.I. Direct Red 36, tetrasodium salt-->Direct Red 264-->DIRECT RED 80-->Direct red 194 (C.I. 35785)-->7,7'-[Ureylenebis[(1-hydroxy-3-sodiosulfonaphthalene-6,2-diyl)azo(4,1-phenylene)azo]]bis[naphthalene-1,3-disulfonic acid disodium] salt-->Direct Red 23 |
|